FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says

cnbc.com/2025/07/11/fda-to-consider-drug-affordability-when-speeding-up-approvals-makary.html

The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals of some treatments, the agency's Commissioner Marty Makary told CNBC on Friday.
The FDA in June announced a national priority voucher plan that aims to cut drug…

This story appeared on cnbc.com, 2025-07-11 13:07:38.
The Entire Business World on a Single Page. Free to Use →